Entrepreneurship for Cardiovascular Health Opportunities (ECHO) is a 12-month national training program supporting cardiovascular research commercialization through education, mentorship, networking, and funding. Led by a diverse team of experts, ECHO fosters...
Entrepreneurship for Cardiovascular Health Opportunities (ECHO) is a 12-month national training program supporting cardiovascular research commercialization through education, mentorship, networking, and funding. Led by a diverse team of experts, ECHO fosters...
The Ted Rogers Centre for Heart Research is thrilled to welcome Dr. Cedric Manlhiot as the inaugural Rogers Innovator of Cardiovascular Precision Medicine at SickKids. In addition to his role at TRCHR, Dr. Manlhiot will be a Scientist in the Translational Medicine...
Entrepreneurship for Cardiovascular Health Opportunities (ECHO) is a 12-month national training program supporting cardiovascular research commercialization through education, mentorship, networking, and funding. Led by a diverse team of experts, ECHO fosters...
Launching in March 2024, emergency department (ED) physicians at the University Health Network (UHN) can now access the Emergency Heart Failure Mortality Risk Grade (EHMRG) calculator within Epic, UHN’s electronic medical record. The EHMRG score estimates the risk of...
Cardiomyopathy is a leading cause of heart failure in children, and there are currently no effective treatments. Could emerging therapies that successfully target the root cause of the condition in adults also work well in children? That was the question Dr....
We build accessible digital health solutions that leverage predictive algorithms and perform unique genomic studies in a bid to drive a person-centred, precision medicine approach to heart failure.
We seek to unravel the unique genome of every child with heart disease/failure in an effort to deliver precision and timely care, prevent complications, and improve outcomes. Learn more
Thank you to the 500 families who have participated in our program that investigates the genetic causes of heart failure in fetuses, children and adults. Learn more
Our Centre is driving a trio of advanced data-driven initiatives that are transforming heart failure research and personalized care now and into the future. Learn more
Through unique research efforts, innovations, and expert clinical care, we protect patients at risk or experiencing heart complications from cancer therapy. Learn more